Results 261 to 270 of about 9,647,508 (315)
Microglial lipid metabolic dysfunction drives neurodegeneration in glaucoma. We found loss of LRP1 causes lipid accumulation and inflammation. We developed alpinetin‐loaded nanoparticles (AlpNPs) that bind LRP1, activate the PPARγ‐LXRα‐ABCA1 pathway to restore lipid homeostasis, promote an anti‐inflammatory phenotype, and protect retinal ganglion cells,
Miao Wei +8 more
wiley +1 more source
New horizons for Parkinson's disease treatment? [PDF]
The Lancet Regional Health-Americas.
europepmc +1 more source
Food for thought: probiotic modulation of microglial activity in Parkinson's disease. [PDF]
Kroker Kimber I, Tremblay MÈ.
europepmc +1 more source
PRKN/PINK1 Mutations in a Chinese Patient With Early-Onset Parkinson's Disease. [PDF]
Lu Z +8 more
europepmc +1 more source
Dispositional and situational empathy in Parkinson's disease and their relationship with cognition. [PDF]
Alonso-Recio L +4 more
europepmc +1 more source
Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial
Joaquim J. Ferreira +7 more
openalex +1 more source
MRI Epicenters Differentiate Spatiotemporal Patterns of Neurodegeneration in Parkinson's Disease. [PDF]
Duanmu X +23 more
europepmc +1 more source
Metabolic Parkinson's disease. [PDF]
Invernizzi F +8 more
europepmc +1 more source

